LEHIGH VALLEY
1. Target Overview & Investment Thesis
LEHIGH VALLEY is a 1190-bed large academic medical center in LEHIGH, PA with $2.84B in net patient revenue and a -5.9% operating margin. The hospital serves a payer mix of 28.8% Medicare, 7.9% Medicaid, and 63.3% commercial.
Thesis: Undervalued. Our ML models identify $209.3M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -5.9% to 1.5% (+736bps).
| Net Revenue HCRIS | $2.84B |
| Current EBITDA COMPUTED | $-167.1M |
| Operating Margin COMPUTED | -5.9% |
| Occupancy HCRIS | 74.5% |
| Revenue / Bed COMPUTED | $2.4M |
| Net-to-Gross HCRIS | 19.1% |
| Distress Probability ML | 44.2% |
2. Market Context & Competitive Position
PA has 225 Medicare-certified hospitals with a median operating margin of -4.4%. The target's margin of -5.9% places it below the state median. Among 8 size-comparable peers (595-2380 beds), the median margin is -7.8%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (595-2380), prioritizing same-state peers. 8 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| LEHIGH VALLEY (Target) | PA | 1190 | $2.84B | -5.9% |
| ST. LUKES HOSPITAL | PA | 633 | $8.94B | 87.9% |
| HOSPITAL OF THE UNIV OF PENNA | PA | 1051 | $3.36B | -12.8% |
| THE CHILDRENS HOSPITAL OF PHIL | PA | 667 | $2.70B | -26.8% |
| UPMC - PRESBYTERIAN SHADYSIDE | PA | 1141 | $2.24B | -23.0% |
| MILTON S. HERSHEY MEDICAL CENT | PA | 616 | $2.08B | -2.8% |
| TEMPLE UNIVERSITY HOSPITAL | PA | 761 | $1.99B | 0.8% |
| THOMAS JEFFERSON UNIV. HOSPITA | PA | 868 | $1.93B | -23.1% |
| LANCASTER GENERAL HOSPITAL | PA | 620 | $1.33B | -2.6% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $209.3M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $59.7M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $56.9M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $56.3M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $34.6M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $1.8M | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-167.1M |
| + RCM Uplift | +$209.3M |
| Pro Forma EBITDA | $42.2M |
| Current Margin | -5.9% |
| Pro Forma Margin | 1.5% |
| WC Released (1x) | $109.1M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-257.1M | $990.7M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-257.1M | $1.01B | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-231.4M | $1.61B | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-231.4M | $1.69B | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-282.8M | $27.7M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-282.8M | $-61.4M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
| Low | Low net-to-gross ratio | Large contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 8 hospitals with 595-2380 beds
- Same-state prioritization (n=9)
- Comp margins: P25=-23.0% / P50=-7.8% / P75=-1.7%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.